课题基金 / 基金详情

项目摘要

项目成果

James Mitchell的其他基金

相似基金

相关文献

中文摘要
翻译
我们已经完成了一项关于肠道微生物区系对辐射致癌的影响的研究。在全身辐射之前,通过在饮用水中使用抗生素鸡尾酒来调节动物的肠道微生物组成。我们发现,与单纯全身照射相比,在全身照射前3周减少肠道微生物区系可缩短小鼠的寿命,暗示肠道微生物区系在辐射诱导的致癌过程中的重要性。我们在小鼠中进行的一项寿命研究即将结束,该小鼠暴露在非致命性3GyTBI中,并在食物中分别使用和不使用雷帕霉素。初步数据显示,与单纯脑损伤相比,雷帕霉素治疗通过减少肝细胞癌的诱发而延长了小鼠的寿命。这项研究将于2022年秋季完成。由于雷帕霉素被FDA批准用于人类,它对辐射诱导的致癌作用提供的保护使其成为暴露在非致命性脑损伤中的人类的合理候选药物。
英文摘要
We have finished a study exploring the influence of the gut microflora on radiation-induced carcinogenesis. The animal's gut microflora composition was modulated by use of an antibiotic cocktail in the drinking water prior to whole body radiation. We found that reducing the gut microflora 3 weeks before total body radiation (TBI) 3 weeks after shortened the lifespan of mice compared to TBI alone, implicating the importance of the gut microflora in radiation-induced carcinogenesis. We are near the end of a life span study in mice exposed to non-lethal 3 Gy TBI with and without rapamycin in their chow. Preliminary data show that rapamycin treatment extended the life span of mice compared to TBI alone by decreasing the induction of hepatocellular carcinomas. The study will be completed by the fall of 2022. Since rapamycin is FDA approved for use in humans, the protection it provides to radiation-induced carcinogenesis makes it a reasonable candidate for humans exposed to non-lethal TBI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nitroxides as Protectors Against Oxidative Stress
Modulation of Therapeutic Response
Modulation of Therapeutic Response
Modulation of Therapeutic Response
海外基金